Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: Behavioral and neurobiological analyses

Metabolic Brain Disease

Volumn 28, Issue 4, 2013, Pages 571-583

  Xu, Ying ^a,b   Zhang, Lu ^a   Shao, Tuo ^a   Ruan, Lina ^a   Wang, Lin ^a   Sun, Jiao ^a   Li, Jianxin ^a   Zhu, Xinbo ^a   O'Donnell, James M ^b   Pan, Jianchun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Allodynia; Antidepressant effect; Depression pain dyad; Ferulic acid; Hyperalgesia

Indexed keywords

CASPASE 3; DOPAMINE; FERULIC ACID; GLUTATHIONE; IMIPRAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NEUROPROTECTIVE AGENT; NITRITE; NORADRENALIN; RESERPINE; SEROTONIN; SUBSTANCE P; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DEPRESSION LIKE BEHAVIOR; DOWN REGULATION; DRUG EFFECT; DRUG STRUCTURE; FRONTAL CORTEX; HIPPOCAMPUS; HOPELESSNESS; HYPERALGESIA; IMMOBILITY; LIPID PEROXIDATION; MALE; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; SIGNAL TRANSDUCTION; UPREGULATION;

MUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COUMARIC ACIDS; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; MICE; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RESERPINE; SEROTONIN;

EID: 84887244597     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9404-4     Document Type: Article

References (60)

1. Adell A (2004) Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms? Curr Drug Targets CNS Neurol Disord 3:113-121
2. Arora V, Kuhad A, Tiwari V, Chopra K (2011) Curcumin ameliorates reserpine-induced pain-depression dyad: behavioral, biochemical, neurochemical and molecular evidences. Pychoneuroendocrinology 36:1570-1581
3. Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433-2445
4. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151
5. Blackwell TS, Christman JW (1997) The role of nuclear factor-κβ in cytokine gene regeneration. Am J Respir Cell Mol Biol 17:3-9
6. Bourin M, Poncelet M, Chermat R, Simon P (1983) The value of the reserpine test in psychopharmacology. Arzneimittelforschung 33:1173-1176
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 76:248-254
8. Brightwell JJ, Taylor BK (2009) Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain. Neuroscience 160:174-185
9. Buege JA, Aust SD (1978) Microsomal lipid-peroxidation. Methods Enzymol 52:302
10. Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebroke RE, Di Monte DA, Emson PC, Miller GW (2007) Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27:8138-8148
11. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63
12. Chen Z, Hagler J, Palombella VJ, Melandri F, Seherer D, Ballard D, Maniatis T (2012) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597
13. Chopra K, Tiwari V, Arora V, Kuhad A (2010) Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy. J Pain 11:950-957
14. Duivis HE, de Jonge P, Penninx BW, Na BY, Cohen BE, Whooley MA (2011) Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 168:913-920
15. Fernandez MA, Saenz MT, Garcia MD (1998) Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J Pharm Pharmacol 50:1183-1186
16. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
17. Golden TR, Hinerfeld DA, Melov S (2002) Oxidative stress and aging: beyond correlation. Aging Cell 1:117-123
18. Goldenberg DL (2010) Pain/depression dyad, a key to a better understanding and treatment of functional somatic syndromes. Am J Med 123:675-682
19. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Ann Biochem 126:131-138
20. Gupta MA (1986) Is chronic pain a variant of depressive illness? A critical review. Can J Psychiatry 31:241-248
21. Harden RN (2005) Chronic neuropathic pain: mechanisms, diagnosis, and treatment. Neurologist 11:111-122
22. Ichikawa H, Nakamura Y, Kashiwada Y, Aggarwal BB (2007) Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr Pharm Des 13:3400-3416
23. Jackson KC II, St Onge EL (2003) Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Practice 3:135-143
24. Jaracz J, Rybakowski J (2005) Depression and pain: novel clinical, neurobiological and psychopharmacological data. Psychiatr Pol 39:937-950
25. Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ (1993) Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 150:734-741
26. Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189-195
27. Kumar A, Garg R, Gaur V, Kumar P (2009) Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice. Neurosci Lett 467:72-75
28. Kumar P, Kalonia H, Kumar A (2011) Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's Disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164:644-654
29. Lee HJ, Lee SY, Kim JH, Sung IK, Park HS, Jin CJ, Kang SG, Yoon H, Chun HJ (2010) Depressive mood and quality of life in functional gastrointerstinal disorders: differences between functional dyspepsia, irritable bowel syndrome and overlap syndrome. Gen Hosp Psychaitry 32:499-502
30. Lee HR, Hwang IS, Kim JE, Choi SI, Lee YJ, Goo JS, Lee EP, Choi HW, Kim HS, Lee JH, Jung YJ, Hwang DY (2012) Altered expression of r-secretase components in animal model of major depressive disorder induced by reserpine administration. Lab Anim Res 28:109-114
31. Lepoivre M, Chenais B, Yapo A, Lemaire G, Thelander L, Tenu JP (1990) Alteration of ribonucleotide reductase activity following induction of nitrite generating pathway in adenocarcinoma cells. J Biol Chem 265:14143-14149
32. Lipowski ZJ (1990) Chronic idiopathic pain syndrome. Ann Med 22:213-217
33. Maes M (2011) An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuro-Psychopharmacol Biol Psychiatry 35:784-794
34. Messay B, Lim A, Marsland A (2012) Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Disord 2:4
35. Mico JA, Ardid D, Berrocoso E, Eschalier A (2006) Antidepressants and pain. Trends Pharmacol Sci 27:348-354
36. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355-474
37. Moron MS, Depierre JW, Mannervik B (1979) Levels of reduced glutathione, glutathione reductase and reduced glutathione s-transferase activities in rat lung and liver. BBA Gen Subj 582:67-78
38. Nagakura Y, Oe T, Aoki T, Matsuoka N (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 146:26-33
39. Nagakura Y, Takahashi M, Noto T, Sekizawa T, Oe T, Yoshimi E, Tamaki K, Shimizu Y (2012) Different pathophysiology underlying animal models of figromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Behav Brain Res 226:242-249
40. Nitta A, Furukawa Y, Hayashi K, Hiramatsu M, Kameyama T, Nabeshima T (1992) Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci Lett 144:152
41. Ogiwara T, Satoh K, Kadoma Y, Murakami Y, Unten S, Atsumi T, Sakagami H, Fujisawa S (2002) Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 22:2711-2717
42. Ozaki Y (1992) Anti-inflammatory effect of tetramethylpyrazine and ferulic acid. Chem Pharm Bull 40:954-956
43. Porsolt RD, Pichon MLE, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressant. Arch Int Pharmacodyn Ther 229:327-336
44. Porsolt RD, Bertin A, Jalfre M (1978) Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291-294
45. Rojas-Corrales MO (2004) Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 18:404-411
46. Sahbaie P, Shi X, Guo TZ, Qiao Y, Yeomans DC, Kingery WS, Clark JD (2009) Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 145:341-349
47. Sharma M, Dash SS, Matharasala G, Deekshith V, Sriram D, Yogeeswari P (2012) Novel piperazinyl derivatives with anti-hyperalgesic, anti-allodynic and anti-inflammatory activities useful for the treatment of neuropathic pain. Antiinflamm Antiallergy Agents Med Chem 11:182-190
48. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85
49. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367-370
50. Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6:662-680
51. Tiwari V, Arora V, Chopra K (2012) Attenuation of NF-κβ mediated apoptotic signaling by tocotrienol ameliorates cognitive deficits in rats postnatally exposed to ethanol. Neurochem Int 61:310-320
52. Von Korff M, Crane P, Lane M, Miglioretti DL, Simon G, Saunders K, Stang P, Brandenburg N, Kessler R (2005) Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain 113:331-339
53. Wang BH, Ou-Yang JP (2005) Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev 23:161-172
54. Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99:667-676
55. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005a) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82:200-206
56. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005b) The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518:40-46
57. Yabe T, Hirahara H, Harada N, Ito N, Nagai T, Sanagi T, Yamada H (2010) Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 165:515-524
58. Yalcin I, Choucair-Jaafar N, Benbouzid M, Tessier LH, Muller A, Hein L, Freund-Mercier MJ, Barrot M (2009) Beta2-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol 65:218-225
59. Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802-809
60. Zhang Y, Huang X, Wang Y, Xie Y, Qiu X (2011) Ferulic acid-induced anti-depression and prokinetics similar to Chaihu-Shugan-San via polypharmacology. Brain Res Bull 86:222-228